Search for Clinical Trial Results

Prolactinoma - 15 Studies Found
Status | Study |
Completed |
Study Name: Cardiac Valve Complications in Prolactinomas Treated With Cabergoline Condition: Prolactinomas Date: 2007-04-13 Interventions: Drug: Cabergoline According with our previous studies, in the patients with microprolactinoma and in tho |
Recruiting |
Study Name: Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus Condition: Invasive Prolactinomas Involving the Cavernous Sinus Date: 2015-08-15 |
Completed |
Study Name: Clomiphene in Males With Prolactinomas and Persistent Hypogonadism Condition:
Date: 2008-06-12 Interventions: Drug: Clomiphene citrate Clomiphene 50 mg/day for 12 weeks |
Completed |
Study Name: Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas Condition:
Date: 2011-09-18 Interventions:
|
Completed |
Study Name: Insulin Resistance in Women With Prolactinoma Condition:
Date: 2017-01-30 Interventions: Drug: Ropinirole |
Recruiting |
Study Name: Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy Condition:
Date: 2009-07-14 Interventions: Drug: Lapatinib All participants will be asked to take Lapatinib daily for six months during the researc |
Recruiting |
Study Name: Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas. Condition: Macroprolactinoma Date: 2010-06-01 Interventions:
|
Recruiting |
Study Name: Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients Condition: Hyperprolactinoma Date: 2011-04-18 Interventions: Drug: Curcumin Curcumin is prescribed to new cases of hyperprolactinoma |
Recruiting |
Study Name: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools Condition:
|